Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Black Rose Industries Ltd
| Standalone Audited Financial Results
Report Source
⬤13th May 26
Summary : Black Rose Industries Limited announced Q4/FY26 results with unmodified audit opinion, recommended dividend, and board re-appointments, while discontinuing a subsidiary.
Quarterly Report Analysis & Insights
Financial Disclosures
- Cost of materials consumed: 6,797.83 Lakhs (FY26 Standalone/Consolidated).
- Purchase of stock-in-trade: 16,700.22 Lakhs (FY26 Standalone/Consolidated).
- Employee benefits expense: 721.77 Lakhs (FY26 Standalone/Consolidated).
- Finance costs: 145.75 Lakhs (FY26 Standalone/Consolidated).
- Depreciation and amortisation expense: 386.81 Lakhs (FY26 Standalone/Consolidated).
- Other expenses: 3,060.05 Lakhs (FY26 Standalone/Consolidated).
- Revenue from operations: 32,301.40 Lakhs (FY26 Standalone/Consolidated).
- Net Cash Flow from Operating Activities: 4,457.98 Lakhs (Standalone FY26), 4,512.27 Lakhs (Consolidated FY26).
- Net Cash Flow from Investing Activities: (2,557.81) Lakhs (Standalone/Consolidated FY26).
- Net Cash Flow from Financing Activities: (1,650.00) Lakhs (Standalone FY26), (1,828.38) Lakhs (Consolidated FY26).
- Net Increase in Cash and Cash Equivalents: 250.17 Lakhs (Standalone FY26), 250.18 Lakhs (Consolidated FY26).
- Total Assets: 20,775.61 Lakhs (Standalone FY26), 20,791.21 Lakhs (Consolidated FY26).
- Equity Share Capital: 510.00 Lakhs (Standalone/Consolidated FY26).
- Other Equity: 16,418.02 Lakhs (Standalone FY26), 16,433.61 Lakhs (Consolidated FY26).
- Trade Receivables: 6,960.57 Lakhs (Standalone/Consolidated FY26).
- Inventories: 4,799.43 Lakhs (Standalone FY26), 4,799.44 Lakhs (Consolidated FY26).
- Mrs. Shruti Jatia is related to Mr. Anup Jatia, Non-Executive Director & Chairman.
- Both standalone and consolidated financial results are presented.
- Consolidated results include B.R. Chemicals Co. Limited as a wholly-owned subsidiary, classified as discontinued operations.
Corporate Overview
- Factory located in Kolhapur, Maharashtra, India.
- Single primary business segment: Chemicals.
- Chemicals
Risk Factors
- Subsidiary operations discontinued, potential impact.
- Reliance on other auditor for subsidiary financials.
- Audit procedures may not detect all misstatements.
- Future events could impact going concern.
Key Drivers
- Recommended final dividend of Re. 1.25.
- Key directors re-appointed for three years.
- New Company Secretary and Compliance Officer appointed.
- Unmodified audit opinion on financial results.
Auditor’s Report
- Unmodified opinion on standalone and consolidated financial results.
Board Commentary
- Mr. Ambarish Daga redesignated from Joint CFO & Investor Relations Officer to Investor Relations Officer.
- Mr. Ambarish Daga re-appointed as Whole-time Director, Executive Director for three years.
- Mrs. Shruti Jatia re-appointed as Whole-time Director, Executive Director for three years.
- Ms. Darshana Sawant appointed as Company Secretary and Compliance Officer.
- M/s. Poddar & Co. appointed as Cost Auditors for FY 2026-27.
- M/s. RMJ & Associates LLP appointed as Internal Auditor for FY 2026-27.
- Recommended final dividend of Re. 1.25 per equity share (125% on paid-up share capital) for FY26, subject to shareholder approval.
- Decision to discontinue operations of wholly-owned subsidiary B.R. Chemicals Co. Ltd. (closure, sale, or transfer of shareholding).
Corporate Governance
- Mr. Ambarish Daga and Mrs. Shruti Jatia not debarred by SEBI or other authority.
- Nomination and Remuneration Committee.
- Audit Committee.